Buy or sell Front Range Biosciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Front Range Biosciences Stock

Agricultural science for cannabis and hemp

About Front Range Biosciences Stock

CEO: Jon Vaught, PhD, Organic Chemistry, CU Boulder, 10 years biotech startup experience with 4 companies CSO: Chris Zalewski, PhD, Plant Biology, UC Davis, 20 years plant biotechnology experience COO: Nick Hofmeister, MBA, MIT, raised $250 million, co-founder 4 biotech companies Problem: Due to 60 years of prohibition, cannabis and hemp cultivators don’t have access to the bioscience tools that are used in modern agriculture. Cannabis and hemp growers are losing money due to disease, reduced yields, and un-differntiated product. Solution: Use known agricultural biotechnology (e.g., tissue culture, cryopreservation, analytical chemistry, genomics and marker assisted breeding) to improve yields, reduce disease, and create novel strains.

Funding History

March 2016$20K
May 2016$50K
February 2017$1.5M
September 2017$3.0M
October 2018$10.0M

Management

CEO, Founder

Jonathan Vaught

COO, Founder

Nick Hofmeister

CSO, Founder

Christopher Zalewski

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Front Range Biosciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo